Applications of (R)-(-)-2-Amino-1-Propanol in Industrial Manufacturing

(R)-(-)-2-Amino-1-Propanol is integral to several advanced manufacturing sectors due to its chiral properties and applicability in specialty syntheses. Our facility delivers consistent high-purity grades for responsible industrial use, meeting strict quality benchmarks across diverse fields. Below, we detail established downstream application scenarios, compliance contexts, formulation insights, production process integration, and finished product forms.

1. Chiral Building Block for Pharmaceutical APIs

Leading pharmaceutical manufacturers employ (R)-(-)-2-Amino-1-Propanol as an enantiomerically pure intermediate in the synthesis of active pharmaceutical ingredients. The molecule's chiral amine group participates in stereoselective transformations central to β-blockers and nucleoside analogs, where precise enantiomeric purity affects safety and efficacy profiles. Its addition occurs in the initial or early-stage synthesis, immediately impacting downstream chemical transformations.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• European Pharmacopoeia Monograph 2.2.46 (Chiral purity)
• U.S. Food and Drug Administration (FDA) 21 CFR Part 211
• Chinese Pharmacopoeia ChP 2020, Chiral Compounds

Typical usage ratio

• 0.8 to 1.2 molar equivalents relative to target API intermediate, adjusted to minimize byproducts and maximize yield

Downstream process integration

• Introduced during asymmetric synthesis or chiral resolution, typically under controlled temperature and inert atmosphere; exact step determined by molecular scaffold of the target API

Final product types

• β-blockers (e.g., propranolol derivatives)
• Chiral nucleoside pharmaceuticals
• Anti-infective agents with enantioselective profiles
• Central nervous system drugs

2. Intermediate in Agrochemical Synthesis

Producers in the agrochemical sector rely on (R)-(-)-2-Amino-1-Propanol to construct chiral intermediates for herbicides and fungicides, mainly when stereochemical outcome influences biological activity or regulatory requirements. Manufacturers control the enantiomer input early in the multi-step route to minimize racemization and ensure downstream formulation quality.

Industry compliance standards

• FAO/WHO Specifications for Agricultural Pesticides
• ISO 16140: Microbiology of Food and Animal Feeding Stuffs
• REACH Regulation (EC) No 1907/2006
• OECD Guidance for Pesticide Residue Analytical Methods

Typical usage ratio

• 5%–10% w/w in precursor synthesis stages, with the ratio fine-tuned against biological activity screening outcomes

Downstream process integration

• Charged as a nucleophilic reactant for amide or carbamate bond formation after the initial core scaffold assembly; temperature and pH tightly monitored to preserve stereochemistry

Final product types

• Enantiopure herbicide actives
• Stereospecific fungicidal ingredients
• Chiral insect control compounds

3. Chiral Ligand Precursor for Asymmetric Catalysis

Industrial catalyst manufacturers utilize this compound to generate chiral ligands for asymmetric hydrogenation or addition reactions. The downstream formulation employs the enantiomer as a skeleton for phosphine or amine-based ligand synthesis, facilitating high selectivity in large-scale chiral molecule production for both pharmaceuticals and fine chemicals.

Industry compliance standards

• ISO 9001:2015 Quality Management Systems
• EU Regulation (EC) No 1272/2008 (CLP)—Safe Handling of Chemical Substances
• Responsible Care Global Charter
• Internal batch testing in accordance with catalyst user protocols

Typical usage ratio

• 15%–20% w/w relative to total ligand system; precise dosing determined by desired stereochemical induction

Downstream process integration

• Added during the initial ligand synthesis, often through reductive amination or phosphorylation steps, integrated via continuous flow or batch reactor processes

Final product types

• Chiral phosphine ligand systems
• Catalysts for asymmetric hydrogenation
• Enantioselective synthesis kits for specialty chemicals

4. Component in Diagnostic Reagent Manufacturing

Producers of clinical diagnostic kits employ (R)-(-)-2-Amino-1-Propanol for the synthesis of conjugates and labeling agents, where chirality and amine functionality are critical in generating reproducible and specific detection reagents. The compound’s chiral center supports stereospecific probe labeling, critical for certain immunoassays and biosensor platforms.

Industry compliance standards

• ISO 13485:2016 Medical Device Quality Management Systems
• IVDD/IVDR (EU Regulation 2017/746 for in vitro diagnostic devices)
• FDA 21 CFR 820 (Quality System Regulation for Medical Devices)
• CLSI EP05: Evaluation of Precision of Quantitative Measurement Procedures

Typical usage ratio

• 0.01%–0.05% in final reagent formulation; rate adapted to probe concentration and conjugation efficiency

Downstream process integration

• Incorporated at the conjugation reaction step during synthesis of detection linkers, followed by purification and QC verification; input timing matches conjugation yield optimization

Final product types

• Immunoassay kits (ELISA, CLIA)
• Fluorescent-labeled diagnostic agents
• Biosensor surface modification reagents
• Clinical chemistry panels

5. Fine Chemical Synthesis for Optical Brighteners

In the fine and specialty chemicals sector, downstream manufacturers incorporate (R)-(-)-2-Amino-1-Propanol for introducing chirality in the core structure of optical brightening agents. The enantiomeric purity controls the spectral behavior and compatibility with polymer matrices, influencing the performance of brighteners used in plastics and detergents.

Industry compliance standards

• OEKO-TEX Standard 100 (textile chemicals safety; polymer applications)
• ISO 14001:2015 Environmental Management (for specialty chemicals)
• GHS (Globally Harmonized System) labeling for chemical safety
• REACH registration (EC/1907/2006)

Typical usage ratio

• 0.5%–2% of the total mass in specialty optical brightener formulations, adjusted per substrate compatibility and brightness requirements

Downstream process integration

• Charged following preparation of the core stilbene or biphenyl backbone, undergoing condensation with sulfonated intermediates under alkaline conditions

Final product types

• Textile optical brightening agents
• Detergent brighteners
• Polymeric whitening additives
• Plastics fluorescence modifiers